Abstract
Amplification of human papillomavirus (HPV) DNA by L1 consensus primer systems (e.g., MY09/11 or GP5(+)/6(+)) can detect as few as 10 to 100 molecules of HPV targets from a genital sample. However, genotype determination by dot blot hybridization is laborious and requires at least 27 separate hybridizations for substantive HPV-type discrimination. A reverse blot method was developed which employs a biotin-labeled PCR product hybridized to an array of immobilized oligonucleotide probes. By the reverse blot strip analysis, genotype discrimination of multiple HPV types can be accomplished in a single hybridization and wash cycle. Twenty-seven HPV probe mixes, two control probe concentrations, and a single reference line were immobilized to 75- by 6-mm nylon strips. Each individual probe line contained a mixture of two bovine serum albumin-conjugated oligonucleotide probes specific to a unique HPV genotype. The genotype spectrum discriminated on this strip includes the high-risk, or cancer-associated, HPV genotypes 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 55, 56, 58, 59, 68 (ME180), MM4 (W13B), MM7 (P291), and MM9 (P238A) and the low-risk, or non-cancer-associated, genotypes 6, 11, 40, 42, 53, 54, 57, 66, and MM8 (P155). In addition, two concentrations of beta-globin probes allowed for assessment of individual specimen adequacy following amplification. We have evaluated the performance of the strip method relative to that of a previously reported dot blot format (H. M. Bauer et al., p. 132-152, in C. S. Herrington and J. O. D. McGee (ed.), Diagnostic Molecular Pathology: a Practical Approach, (1992), by testing 328 cervical swab samples collected in Digene specimen transport medium (Digene Diagnostics, Silver Spring, Md.). We show excellent agreement between the two detection formats, with 92% concordance for HPV positivity (kappa = 0.78, P < 0.001). Nearly all of the discrepant HPV-positive samples resulted from weak signals and can be attributed to sampling error from specimens with low concentrations (<1 copy/microliter) of HPV DNA. The primary advantage of the strip-based detection system is the ability to rapidly genotype HPVs present in genital samples with high sensitivity and specificity, minimizing the likelihood of misclassification.
MeSH Terms
Animals
Base Sequence
Biotinylation
Cattle
Cervix Uteri/virology
Consensus Sequence
Female
Genotype
Humans
Oligonucleotide Probes
Papillomaviridae/classification,genetics,isolation & purification
Papillomavirus Infections/virology
Polymerase Chain Reaction/methods
Random Amplified Polymorphic DNA Technique
Sensitivity and Specificity
Tumor Virus Infections/virology
Chemicals
Oligonucleotide Probes
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gravitt P E
Department of Human Genetics, Roche Molecular Systems, Inc., Alameda, California 94501, USA.
Peyton C L
Apple R J
Wheeler C M
References (18)
18 references, click to expand
-
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.
Am J Clin Pathol. 1994 Aug;102(2):182-7
PMID: 8042586
-
Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses.
J Infect Dis. 1994 Nov;170(5):1096-9
PMID: 7963700
-
A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes.
Tissue Antigens. 1994 Sep;44(3):137-47
PMID: 7839345
-
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
Am J Obstet Gynecol. 1995 Mar;172(3):946-54
PMID: 7892889
-
The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.
Int J Cancer. 1995 May 4;61(3):306-11
PMID: 7729939
-
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.
J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
PMID: 7791229
-
Human papillomavirus testing in primary cervical screening.
Lancet. 1995 Jun 17;345(8964):1533-6
PMID: 7791438
-
New epidemiology of human papillomavirus infection and cervical neoplasia.
J Natl Cancer Inst. 1995 Sep 20;87(18):1345-7
PMID: 7658490
-
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
J Natl Cancer Inst. 1995 Sep 20;87(18):1365-71
PMID: 7658497
-
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan.
Int J Cancer. 1995 Sep 4;62(5):565-71
PMID: 7665227
-
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.
J Clin Microbiol. 1997 Mar;35(3):791-5
PMID: 9041439
-
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.
J Clin Microbiol. 1997 Jun;35(6):1304-10
PMID: 9163434
-
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
N Engl J Med. 1992 Oct 29;327(18):1272-8
PMID: 1328880
-
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
J Natl Cancer Inst. 1993 Jun 16;85(12):958-64
PMID: 8388478
-
Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia.
Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):415-22
PMID: 8220085
-
Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes.
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6230-4
PMID: 2762325
-
The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection.
Epidemiology. 1991 Mar;2(2):98-106
PMID: 1657209
-
Persistence of type-specific human papillomavirus infection among cytologically normal women.
J Infect Dis. 1994 Feb;169(2):235-40
PMID: 8106758